Infection  >>  tenofovir disoproxil fumarate  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tenofovir disoproxil fumarate / Generic mfg.
COVER, NCT00705419 / 2006-003463-31: Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)

Completed
N/A
180
US
Vicriviroc maleate, SCH 417690, Placebo, Emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg, Truvada
Merck Sharp & Dohme LLC
HIV Infections
09/10
09/10
NCT01728935: Tenofovir in Asian Chronic Hepatitis B Patients

Completed
N/A
141
RoW
Tenofovir disoproxil, Viread
The University of Hong Kong, Gilead Sciences
Chronic Hepatitis B
11/12
03/13
NCT02258581 / 2015-001050-16: Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection

Terminated
N/A
241
US, Canada, Europe, RoW
GS-4774, GS-9620, Tenofovir disoproxil fumarate (TDF), Viread®
Gilead Sciences
Chronic Hepatitis B
08/17
08/17

Download Options